Ductal adenocarcinoma of the head of the pancreas: A critical study of R1 resection rates;Adénocarcinomes pancréatiques céphaliques: Une étude critique du taux des marges de résection positives

Bulletin du Cancer

Volumn 95, Issue 12, 2008, Pages 1193-1198

  Delpero, J R ^a   Turrini, O ^a  

^a INSTITUT PAOLI CALMETTES   (France)

Author keywords

Margins of resection; Pancreatic cancer; Pancreaticoduodenectomy

Indexed keywords

ARTICLE; CANCER RECURRENCE; CANCER SURGERY; CORRELATIONAL STUDY; DUCTAL ADENOCARCINOMA; FRANCE; HEALTH CARE QUALITY; MEDICAL LITERATURE; METASTASIS; PANCREAS ADENOCARCINOMA; PANCREATICODUODENECTOMY;

CARCINOMA, PANCREATIC DUCTAL; HUMANS; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; PANCREAS; PANCREATECTOMY; PANCREATIC NEOPLASMS; PROGNOSIS;

EID: 58149347810     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: 10.1684/bdc.2008.0762     Document Type: Article

References (29)

1. Verbeke CS, Leitch D, Menon KV, McMahon MJ, Guillou PJ, Anthoney A, et al. Redefining the R1 resection in pancreatic cancer. Br J Surg 2006 ; 93 : 1232-7.
2. Esposito I, Kleeff J, Bergmann F, Reiser C, Herpel E, Friess H, et al. Most pancreatic cancer resections are R1 resections. Ann Surg Oncol 2008 ; 15(6) : 1651-60.
3. Riall TS, Cameron JL, Lillemoe KD, Campbell KA, Sauter PK, Coleman J, et al. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma - part 3: update on 5-year survival. J Gastrointest Surg 2005 ; 9 : 1191-204.
4. Willett CG, Lewandrowski K, Warshaw AL, Efird J, Compton CC. Resection margins in carcinoma of the head of the pancreas. Implications for radiation therapy. Ann Surg 1993 ; 217 : 144-8.
5. Staley CA, Cleary KR, Abbruzzese JL, Lee JE, Ames FC, Fenoglio CJ, et al. The need for standardized pathologic staging of pancreaticoduodenectomy specimens. Pancreas 1996 ; 12 : 373-80.
6. Luttges J, Vogel I, Menke M, Henne-Bruns D, Kremer B, Klöppel G, et al. The retroperitoneal resection margin and vessel involvement are important factors determining survival after pancreaticoduodenectomy for ductal adenocarcinoma of the head of the pancreas. Virchows Arch 1998 ; 433 : 237-42.
7. Exocrine pancreas. In : Greene FL, Page DL, Fleming ID, et al., eds. AJCC Cancer Staging Manual. Chicago : Springer, 2002 : 157-64.
8. http://www.rcpath.org/ Minimum data set for the histopathological reporting of pancreatic cancer of the Royal College of Pathologists.
9. http://www.cap.org/.
10. Wagner M, Redaelli C, Lietz M, Seiler CA, Friess H, Büchler MW, et al. Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma. Br J Surg 2004 ; 91 : 586-94.
11. Pingpank JF, Hoffman JP, Ross EA, Cooper HS, Meropol NJ, Freedman G, et al. Effect of preoperative chemoradiotherapy on surgical margin status of resected adenocarcinoma of the head of the pancreas. J Gastrointest Surg 2001 ; 5 : 121-30.
12. Tseng JF, Raut CP, Lee JE, Pisters PW, Vauthey JN, Abdalla EK, et al. Pancreaticoduodenectomy with vascular resection: margin status and survival duration. J Gastrointest Surg 2004 ; 8 : 935-50.
13. Raut CP, Tseng JF, Sun CC, Wang H, Wolff RA, Crane CH, et al. Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg 2007 ; 246(1) : 52-60.
14. Brennan MF, Kattan MW, Klimstra D, Conlon K. Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas. Ann Surg 2004 ; 240(2) : 293-8.
15. Neoptolemos JP, Stocken DD, Dunn JA, Almond J, Beger HG, Pederzoli P, et al. Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant ehemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. Ann Surg 2001 ; 234(6) : 758-68.
16. Evans DB, Hess KR, Pisters PWT. Ann Surg 2002 ; 236(5) : 694 (author reply 694-6).
17. Sauvanet A, Delpero JR. Critères de qualité en chirurgie carcinologique digestive, recommandations de la Société francaise de chirurgie digestive (SFCD) et de l'Association de chirurgie hépatobiliaire et de transplantation hépatique (ACHBT). HAS-Inca, 2008.
18. Kawarada Y. New classification of pancreatic carcinoma. Japan Pancreas Society. Nippon Shokakibyo Gakkai Zasshi 2003 ; 100 : 974-80.
19. Matsuno S, Egawa S, Fukuyama S, Motoi F, Sunamura M, Isaji S, et al. Pancreatic Cancer Registry in Japan: 20 years of experience. Pancreas 2004 ; 28 : 219-30.
20. Richelme H, Birstwisle Y, Michetti C, Bourgeon A. La section de la lame rétropancréatique droite au cours de la duodé nopancréatectomie céphalique. Modalités techniques. Ann Chir 1986 ; 40 : 401-4.
21. Talamonti MS, Small Jr. W, Mulcahy MF, Wayne JD, Attaluri V, Colletti LM, et al. A multi-institutional phase II trial of preoperative full-dose gemcitabine and concurrent radiation for patients with potentially resectable pancreatic carcinoma. Ann Surg Oncol 2006 ; 13(2): 150-8.
22. Delpero JR, Turrini O. Adénocarcinomes pancréatiques localement évolués. Chimioradiothérapie, réévaluation et résection secondaire ? Cancer Radiother 2006 ; 10 : 462-70.
23. Sasson AR, Hoffman JP, Ross EA, Kagan SA, Pingpank JF, Eisenberg BL, et al. En bloc resection for locally advanced cancer of the pancreas: is it worthwhile? J Gastrointest Surg 2002 ; 6 : 147-58.
24. Yeo CJ, Cameron JL, Sohn TA, Lillemoe KD, Pitt HA, Talamini MA, et al. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990's. Pathology, complications and outcomes. Ann Surg 1997 ; 226 : 248-60.
25. Takai S, Satoi S, Toyokawa H, Yanagimoto H, Sugimoto N, Tsuji K, et al. Clinicopathologic evaluation after resection for ductal adenocarcinoma of the pancreas: a retrospective, single-institution experience. Pancreas 2003 ; 26(3) : 243-9.
26. Mu DQ, Peng SY, Wang GF. Extended radical operation of pancreatic head cancer: appraisal of its clinical significance. World J Gastroenterol 2005 ; 11 : 2467-71.
27. Autschbach F. The pathological assessment of total mesorectal excision: what are the relevant resection margins? Recent Results Cancer Res 2005 ; 165 : 30-9.
28. Verbeke CS. Resection margins and R1 rates in pancreatic cancer - are we there yet? Histopathology 2008 ; 52(7) : 787-96.
29. Kim J, Reber HA, Dry SM, Elashoff D, Chen SL, Umetani N, et al. Unfavourable prognosis associated with K-ras gene mutation in pancreatic cancer surgical margins. Gut. 2006 Nov;55(11):1598-605. Epub 2006 May 8. Erratum in. Gut 2006 ; 55(12) : 1824.